SINT Sintx Technologies, Inc.
Healthcare$2.43+1.67%ClosedMarket Cap: $6.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
10.61
P/S
6.44
EV/EBITDA
-0.74
DCF Value
$-8.01
FCF Yield
-149.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
-32.7%
Operating Margin
-1122.0%
Net Margin
-1711.6%
ROE
-592.5%
ROA
-225.5%
ROIC
-284.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $380.0K | -3.2% | $-3.2M | $-2.8M | $— | — |
| Q4 null | $341.0K | -124.0% | $-2.3M | $-2.2M | $— | — |
| FY null | $1.0M | -19.7% | $-10.7M | $-17.1M | $— | — |
| Q3 null | $208.0K | 44.7% | $-3.4M | $-10.3M | $— | — |
| Q2 null | $100.0K | 6.0% | $-2.7M | $-2.3M | $— | — |
| Q1 null | $369.0K | 33.3% | $-2.4M | $-2.3M | $— | — |
| Q4 null | $542.0K | 71.6% | $-1.7M | $-1.7M | $— | — |
| FY null | $1.2M | 34.9% | $-14.0M | $-11.0M | $— | — |
| Q3 null | $367.0K | 42.8% | $-6.4M | $-6.2M | $— | — |
| Q2 null | $378.0K | 40.7% | $-2.7M | $-2.2M | $— | — |
| Q1 null | $309.0K | 27.8% | $-3.2M | $-886.0K | $— | — |
| Q4 2023 | $902.0K | 50.7% | $-2.7M | $-2.3M | $-6.04 | — |